methylphosphonothiolate has been researched along with Ovarian Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Atkinson, EN; Auersperg, N; Fang, X; Felix, EA; Hasegawa, Y; Lapushin, R; Mills, GB; Morris, AJ; Newman, RA; Sigal, YJ; Tanyi, JL; Wolf, JK | 1 |
1 other study(ies) available for methylphosphonothiolate and Ovarian Neoplasms
Article | Year |
---|---|
The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer.
Topics: Apoptosis; Cell Division; Enzyme Activation; Female; Genetic Therapy; Humans; Hydrolysis; Lysophospholipids; Organothiophosphorus Compounds; Ovarian Neoplasms; Phosphatidate Phosphatase; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, Lysophosphatidic Acid; Signal Transduction; Transfection; Tumor Cells, Cultured | 2003 |